GNF-6231
10mM in DMSO
- Product Code: 190224
CAS:
1243245-18-2
| Molecular Weight: | 448.49 g./mol | Molecular Formula: | C₂₄H₂₅FN₆O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30343851 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
GNF-6231 is a potent and selective inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH), which plays a critical role in the de novo pyrimidine biosynthesis pathway. By inhibiting DHODH, GNF-6231 effectively disrupts the production of uridine monophosphate, a key building block for RNA and DNA synthesis, particularly in rapidly dividing cells.
This mechanism makes GNF-6231 a promising candidate in antiviral therapy, especially against RNA viruses such as flaviviruses, including dengue, Zika, and hepatitis C virus. These viruses rely heavily on the host cell’s nucleotide pool for replication, and by limiting pyrimidine availability, GNF-6231 can significantly reduce viral replication without high toxicity to host cells.
In addition to antiviral applications, GNF-6231 has been explored in oncology research due to the high metabolic demands of cancer cells. Tumor cells often depend on de novo nucleotide synthesis for proliferation, making DHODH inhibition a potential strategy to slow or halt tumor growth. Studies have shown that GNF-6231 can induce cell cycle arrest and apoptosis in certain cancer cell lines.
GNF-6231 is also used as a research tool in cellular and molecular biology to study pyrimidine metabolism, immune cell activation, and virus-host interactions. Its selectivity and potency make it valuable for probing the role of DHODH in various disease models.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿7,200.00 |
+
-
|
GNF-6231
GNF-6231 is a potent and selective inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH), which plays a critical role in the de novo pyrimidine biosynthesis pathway. By inhibiting DHODH, GNF-6231 effectively disrupts the production of uridine monophosphate, a key building block for RNA and DNA synthesis, particularly in rapidly dividing cells.
This mechanism makes GNF-6231 a promising candidate in antiviral therapy, especially against RNA viruses such as flaviviruses, including dengue, Zika, and hepatitis C virus. These viruses rely heavily on the host cell’s nucleotide pool for replication, and by limiting pyrimidine availability, GNF-6231 can significantly reduce viral replication without high toxicity to host cells.
In addition to antiviral applications, GNF-6231 has been explored in oncology research due to the high metabolic demands of cancer cells. Tumor cells often depend on de novo nucleotide synthesis for proliferation, making DHODH inhibition a potential strategy to slow or halt tumor growth. Studies have shown that GNF-6231 can induce cell cycle arrest and apoptosis in certain cancer cell lines.
GNF-6231 is also used as a research tool in cellular and molecular biology to study pyrimidine metabolism, immune cell activation, and virus-host interactions. Its selectivity and potency make it valuable for probing the role of DHODH in various disease models.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :